Dawn Gardner

Dawn Gardner is currently the Vice President of Program Management at Immunovant, bringing extensive experience in clinical operations and project management. They previously held positions as Executive Director of Clinical Operations at OncoBay Clinical and worked at Syneos Health in various senior roles, including Sr. Project Director and Vice President of Clinical Development. Additionally, Dawn served as Program Manager for the Multiple Myeloma Precision Health Initiative at Indiana University School of Medicine and began their career as a forensic chemist at the Indianapolis Marion County Forensic Services Agency. Dawn earned a B.S. in Chemistry and Biology from the University of Indianapolis and an MBA from Northeastern University.